Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael Untch"'
Autor:
Melitta Beatrice Köpke, Carl Mathis Wild, Mariella Schneider, Nicole Pochert, Felicitas Schneider, Jacqueline Sagasser, Thorsten Kühn, Michael Untch, Christian Hinske, Matthias Reiger, Claudia Traidl-Hoffmann, Christian Dannecker, Udo Jeschke, Nina Ditsch
Publikováno v:
Cancers, Vol 15, Iss 14, p 3606 (2023)
The collective of the SerMa pilot study included 100 cases of primary breast cancer or Carcinoma in situ who had undergone a mastectomy procedure with or without reconstruction of the breast using an implant or expander at Augsburg University Hospita
Externí odkaz:
https://doaj.org/article/b6daf09bd99f47b38aae5c91646f7528
Autor:
Bernd Gerber, Andreas Schneeweiss, Volker Möbus, Michael Golatta, Hans Tesch, David Krug, Claus Hanusch, Carsten Denkert, Kristina Lübbe, Jörg Heil, Jens Huober, Beyhan Ataseven, Peter Klare, Markus Hahn, Michael Untch, Karin Kast, Christian Jackisch, Jörg Thomalla, Fenja Seither, Jens-Uwe Blohmer, Kerstin Rhiem, Peter A. Fasching, Valentina Nekljudova, Sibylle Loibl, Thorsten Kühn
Publikováno v:
Cancers, Vol 14, Iss 3, p 521 (2022)
Background: The conversion of initially histologically confirmed axillary lymph node-positive (pN+) to ypN0 after neoadjuvant systemic treatment (NAST) is an important prognostic factor in breast cancer (BC) patients and may influence surgical de-esc
Externí odkaz:
https://doaj.org/article/17e84cdca4604002ae0a7a1cf9a85dd2
Autor:
Laura L. Michel, Andreas D. Hartkopf, Peter A. Fasching, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Bernhard Volz, Hanna Huebner, Pauline Wimberger, Carsten Hielscher, Christoph Mundhenke, Christian Kurbacher, Rachel Wuerstlein, Michael Untch, Friedrich Overkamp, Jens Huober, Wolfgang Janni, Florin-Andrei Taran, Michael P. Lux, Diethelm Wallwiener, Sara Y. Brucker, Andreas Schneeweiss, Tanja N. Fehm
Publikováno v:
Cancers, Vol 12, Iss 10, p 3021 (2020)
The approval of trastuzumab emtansine (T-DM1) was conducted without pertuzumab as previous therapy. Efficacy data on T-DM1 following pertuzumab treatment are therefore limited. This study explores this issue in a real-world setting. Within the prospe
Externí odkaz:
https://doaj.org/article/c7f59ccc2fee4f36a2ba574fae16c632
Autor:
Serena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, Marco Silvestri, José Baselga, Martine Piccart, Jens Huober, Miguel Izquierdo, Lorena de la Pena, Florentine S. Hilbers, Evandro de Azambuja, Michael Untch, Lajos Pusztai, Kathleen Pritchard, Paolo Nuciforo, Anne Vincent-Salomon, Fraser Symmans, Giovanni Apolone, Filippo G. de Braud, Marilena V. Iorio, Paolo Verderio, Maria Grazia Daidone
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1386 (2020)
Circulating microRNA (ct-miRNAs) are able to identify patients with differential response to HER2-targeted therapy. However, their dynamics are largely unknown. We assessed 752 miRNAs from 52 NeoALTTO patients with plasma pairs prior and two weeks af
Externí odkaz:
https://doaj.org/article/c17c91ee4a3944f1a25b0f0df0cf277b
Autor:
Malgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, Christoph Mundhenke, Bianca Lederer, Christine Solbach, Thomas Karn, Frederik Marmé, Valentina Nekljudova, Christian Schem, Elmar Stickeler, Nicholas Willumsen, Morten A. Karsdal, Michael Untch, Volkmar Müller
Publikováno v:
Cancers, Vol 11, Iss 8, p 1186 (2019)
Background: Remodeling of extracellular matrix through collagen degradation is a crucial step in the metastatic cascade. The aim of this study was to evaluate the potential clinical relevance of the serum collagen degradation markers (CDM) C3M and C4
Externí odkaz:
https://doaj.org/article/b64d57df09ef4879919b5a3bcd99c794
Autor:
Michael P. Lux, Naiba Nabieva, Andreas D. Hartkopf, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias W. Beckmann, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Matthias Geberth, Wolfgang Abenhardt, Christian Kurbacher, Rachel Wuerstlein, Christoph Thomssen, Michael Untch, Peter A. Fasching, Wolfgang Janni, Tanja N. Fehm, Diethelm Wallwiener, Andreas Schneeweiss, Sara Y. Brucker
Publikováno v:
Cancers, Vol 11, Iss 1, p 10 (2018)
This study presents comprehensive real-world data on the use of anti-human epidermal growth factor receptor 2 (HER2) therapies in patients with HER2-positive metastatic breast cancer (MBC). Specifically, it describes therapy patterns with trastuzumab
Externí odkaz:
https://doaj.org/article/65d2d1d638c5451da23b7323d3575a0b
Autor:
Bianca Lederer, Morten A. Karsdal, Volkmar Müller, Michael Untch, Thomas Karn, Christine Solbach, Christoph Mundhenke, Elmar Stickeler, Christian Schem, Isabell Witzel, Frederik Marmé, Nicholas Willumsen, Sibylle Loibl, Malgorzata Banys-Paluchowski, Valentina Nekljudova
Publikováno v:
Cancers, Vol 11, Iss 8, p 1186 (2019)
Cancers 11(8), (2019). doi:10.3390/cancers11081186
Cancers
Volume 11
Issue 8
Cancers 11(8), (2019). doi:10.3390/cancers11081186
Cancers
Volume 11
Issue 8
Background: Remodeling of extracellular matrix through collagen degradation is a crucial step in the metastatic cascade. The aim of this study was to evaluate the potential clinical relevance of the serum collagen degradation markers (CDM) C3M and C4